Aims. Giant cell
Aims. The present study investigated receptor activator of nuclear factor kappa-Β ligand (RANKL), osteoprotegerin (OPG), and Runt-related transcription factor 2 (RUNX2) gene expressions in giant cell
Aims. Local recurrence remains a challenging and common problem following curettage and joint-sparing surgery for giant cell
Aims. Giant cell
Introduction: Giant cell
Giant-cell
1. Fifty-five giant-cell
AIM. To present our experience in patients treated under primary diagnosis giant cell
Aims. The aim of this paper was to investigate the prognostic factors for local recurrence in patients with pathological fracture through giant cell
Because of the lack of a suitable in vivo model for giant cell
Giant cell
Benign aggressive tumors are common and can be debilitating for patients especially if they are in peri-articular regions or cause pathological fracture as is common for giant cell
Various chemicals are commonly used as adjuvant treatment to surgery for giant-cell
Giant cell
Background. Giant cell
We have reviewed 13 operations on 11 patients using curettage and polymethylmethacrylate cement for giant-cell
Objectives: Development a giant cell tumor model arising from the mutated mesenchymal cells present in its stroma. This establishes the pathogenic mechanism of giant cell tumor, and allows the evaluation of the possible role of biphosphonates and retinoic acid in medical therapy of giant cell
We reviewed 23 patients with a giant-cell
The giant cell
Introduction. Local recurrence of Giant cell